Vor bio to participate in upcoming investor conferences

Cambridge, mass., nov. 01, 2022 (globe newswire) -- vor bio (nasdaq: vor), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

VOR Ratings Summary

VOR Quant Ranking